Novo Nordisk Investigational Site

Augusta, Georgia 30912-3260

0 studies enrolling now · 13 studies all time

What they study most

Acquired Bleeding Disorder, Anemia, Chronic Kidney Disease, Congenital Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 2, End-Stage Renal Disease, Haemophilia A, Haemophilia A With Inhibitors, Haemophilia B, Haemophilia B With Inhibitors, Intracerebral Haemorrhage

Studies at this site

• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) — Completed
• Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 — Completed
• Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A — Completed
• Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A — Completed
• Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes — Stopped early
• Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 — Completed
• Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B — Completed
• Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients — Completed
• Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A — Completed
• Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early
• Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds — Completed
• Recombinant Factor VIIa in Acute Intracerebral Haemorrhage — Completed